All Type of News
Government clarifies stance on cost-effectiveness assessment of statin preparations
The Health Insurance Review Agency said on May 16 that its assessment on the cost-effectiveness of new antihyperlipidemic agents is entirely based on scientific evidences, expressing its regret over miscommunication b...
Voters' support to determine winner of by-election
With the by-election approaching to select the chairman of the Korean Pharmaceutical Association, 20,000 voters have yet to support their candidates.
The KPA chairman Won Hee-mok of the Korean Pharmaceutical Associ...
Third-party deposit system to take place by September
The new third-party deposit system, which has been actively promoted by the Korea Pharmaceutical Manufacturers Association, will be implemented in September, according to a KPMA official.
The KPMA plans to nurture ...
Korea's technical export revenues surpass $230 million
The nation's total technical export volume has topped $230.8 million over the past five years, with its total technical import volume posting $124.0 million for the cited period, the Korea Drug Research Associat...
ICURE launches Ato-P hydrogel gel patchICURE Pharmaceutical Inc., a local biopharmaceutical company, says it has launched a novel type of hydrogel patch 'Ato-P hydrogel gel patch' to alleviate skin reactions associat...
|
Health insurance allowance possible for 6 cholesterol-lowering agent
The Health Insurance Review Agency announced on May 15 revised terms for health insurance allowance for six items need for the treatment of hyperlipidemia.
In the case of simvastatin, patients can get reimbursed as...
Two biz groups urged to maintain collaboration
Pharmaceutical sources say that attention is being focused on the re-creation of mutual collaboration between the Korea Pharmaceutical Manufacturers Association (KPMA) and the Korean Research-based Pharmaceutical Indu...
LG Life Sciences targets W1.5 tril. in sales by 2015
LG Life Sciences aims to achieve 1.5 trillion won in annual sales by 2015 with the intention of emerging as one of the best-performing companies in the world, a company executive said on May 16.
We will reach 1.5 t...
Health ministry taps price of new AIDS drug
The Ministry of Health, Welfare and Family Affairs says it proposed that Roche Korea supply Fuzeon (enfuvirtide), Roche's new AIDS drug should be supplied at the insurance price 25,000 won.
However, the maker of th...
Dongwha to enhance Helmin 200 image as liver detoxidant in pharmcy
Dongwha Pharm plans to build the image up its OTC product Helmin (arginine tidiacicate) 200 as a next-generation liver detoxidant in pharmacy market.
According to Dongwha, the sales of Helmin 200 are expected to re...
